Cambridge Consultants Ltd

The deep tech powerhouse of Capgemini, delivering breakthrough innovation through a unique offering of biology, engineering and digital technologies.

As the deep tech powerhouse of Capgemini, Cambridge Consultants (CC), is a global team of 800, united by the ambition to turn brilliant ideas into technologies, products and services that have never been seen before. And which will transform business, society and the planet. Deep tech is a mindset; a bold strategy that harnesses radical science and engineering to achieve things no-one else can. It enables our clients to gain unassailable commercial advantage from defendable technology that they own. In biotechnology we work at a powerful sweet spot – the intersection of biology, engineering and digital technologies. We help clients navigate the end-to-end journey from ambition to commercial impact by leveraging our experience across multi-disciplinary technologies. Beyond our advisory teams, which help organisations compete and flourish in the growing bioeconomy, we also develop AI-driven biology that accelerates the discovery of high-performing biomolecules and create engineering and technology innovation that enables economically viable bioproduct manufacture. Cambridge Consultants is trusted by some of the world’s biggest brands and most ambitious start-ups to realise their critical technology-based aspirations – and we’ve been doing it for more than 60 years. We are part of Capgemini Invent.

• Genetics/Genomics
• Engineered Biology
• Medical Devices
• Diagnostics
• Diabetes
• Platform Technology
• Eye Health
• Biofuels/Agricultural
• Digital Health
• Enzyme
• Biomarkers
• ATMP